Automatic External Defibrillation Monitoring in Cardiac Arrest

Completed · Phase 1

Conditions studied: Death, Sudden, Cardiac, Ventricular Fibrillation, Tachycardia, Ventricular

In brief

We propose to randomize automatic external cardioverter/defibrillators (AECD) in patients who are at high risk for life-threatening abnormal heart rhythms (arrhythmias) and are admitted to the telemetry ward, all other treatments being constant including cardiopulmonary resuscitation. We hypothesize that the automatic, rapid, accurate and specific diagnostic and therapeutic technology used in AECDs will further increase the rate of survival in patients with cardiac arrest through rapid and automatic defibrillation, independent of operator initiation, as compared to standard cardiopulmonary resuscitation initiated by healthcare providers.

Key facts

Study ID

NCT00382928

Run by

Foundation for Atlanta Veterans Education and Research, Inc.

People needed

192

Starts

2006-10-01

Expected to finish

2009-09-01

Last updated by the study team

2015-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients admitted to telemetry ward and emergency department
• Age > 18 years.

You may not qualify if…

• Pregnant women
• Patients with R wave less than 0.5 millivolts.
• Patients with functioning Internal Cardiac Device.
• Patients with cardiac pacemakers if oversensing by AECD is demonstrated (double counting of pacer spikes).
• Patients with visible chest lesions that would prevent AECD pad placement.
• Patients who are designated Do Not Resuscitate.
• Right bundle branch block.
• Patients with Parkinson's disease.
• Patients with seizure disorders

Where it is running

• Atlanta Veterans Adminstration Medical Center — Decatur, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.